Volume 110, Issue 5, Pages 905–909
Pietro Bortoletto, M.D., Malavika Prabhu, M.D., Elizabeth M. Garry, M.P.H., Krista F. Huybrechts, M.S., Ph.D., Raymond M. Anchan, M.D., Ph.D., Brian T. Bateman, M.D., M.Sc.
To study opioid dispensing patterns following oocyte retrieval.
Women undergoing oocyte retrieval with a maximum of 1 opioid prescription in the 12 weeks prior to the procedure, without an opioid use or other substance use disorder.
Main Outcome Measure(s)
We measured the frequency of opioids dispensed within 3 days of oocyte retrieval, most common opioids dispensed; and quantity dispensed, in median (interquartile range [IQR] and 10th–90th percentile ranges) oral morphine milligram equivalents (MME). Multivariate regression analyses were used to calculate odds ratios and 95% confidence intervals (CI) to examine the association between patient characteristics and the occurrence of an opioid dispensing.
In total, 61,463 women with an oocyte retrieval met the criteria for analysis. After oocyte retrieval, 11.9% were dispensed an opioid, most commonly hydrocodone (48.5%), codeine (23.0%), and oxycodone (17.7%). The median (IQR; 10th–90th percentile) oral MME dose dispensed after retrieval was 90 (50–125; 50–207). Women with mood disorders (adjusted odds ratio [aOR] 1.17, 95% CI 1.00–1.36), tobacco use (aOR 1.67, 95% CI 1.18–2.37), or anti-depressant use (aOR 1.62, 95% CI 1.47–1.80) were more likely to fill an opioid prescription, compared to those without these diagnoses.
Although only a small proportion of women fill a prescription for opioids after oocyte retrieval, there is substantial variation in the amount dispensed. Patients with a concurrent mood disorder or those taking anti-depressants were more likely to fill an opioid prescription.